Pycnogenol is a standardized extract from French maritime pine bark (Pinus pinaster) containing a complex mixture of procyanidins, bioflavonoids, and organic acids. Its primary mechanisms relevant to erectile function: stimulation of endothelial NOS (eNOS) enzyme activity (increasing NO production from existing arginine), antioxidant protection of NO from free radical degradation, and improvement of endothelial function across vascular beds. Stanislavov & Nikolova (2003) studied 40 men aged 25–45 without confirmed organic ED in a 3-month sequential design without a placebo group: L-arginine alone for the first month produced a normal erection in 5% of men, adding Pycnogenol in the second month raised this to 80%, and a higher Pycnogenol dose in the third month raised it to 92.5% [1]. The synergy: L-arginine provides NOS substrate, pycnogenol enhances NOS enzyme activity.
Are These Results Too Good to Be True? Short Answer
The 80-92.5% normalization figures are genuinely striking compared to most supplement research in this space, and that alone is worth addressing directly rather than glossing over. These results come from a small trial (n=40) conducted by a single research group, and independent large-scale replication by other investigators is limited — this is a real evidence-quality limitation worth naming honestly, even though the mechanism (eNOS stimulation combined with arginine substrate supply) is biologically plausible and consistent with well-established vascular pharmacology. This combination doesn't have the same evidence weight as, say, PDE5 inhibitor trials, which have been replicated across dozens of large, independently-funded studies. A reasonable interpretation: the pycnogenol + L-arginine combination is one of the more promising supplement combinations for mild-to-moderate vascular ED specifically, worth a genuine trial given its favorable safety profile, but the specific percentage figures from a single small trial shouldn't be treated as a guaranteed outcome the way they sometimes are in supplement marketing that cites this study.
Clinical Evidence
- •Stanislavov & Nikolova 2003 (n=40 men aged 25–45 without confirmed organic ED): L-arginine (1.7g/day) alone for month 1 → 5% normal erection; + Pycnogenol 80mg/day in month 2 → 80%; 120mg/day in month 3 → 92.5%; no placebo group [1]
- •Second Stanislavov trial: similar design, confirmed results in separate cohort
- •Mechanism: pycnogenol stimulates eNOS enzyme activity without providing additional substrate — directly complements L-arginine (substrate) supplementation
- •Vascular benefit: pycnogenol also reduces platelet aggregation, improves microcirculation, and reduces endothelial inflammation — beneficial for vascular ED etiology
- •Antioxidant: procyanidins scavenge superoxide and peroxynitrite that would otherwise destroy NO — preserves NO bioavailability in oxidative stress states
- •Diabetic ED specific data: small studies show pycnogenol improves endothelial function in diabetic patients — relevant for the most common organic ED etiology
Dosing and Combinations
- •Pycnogenol monotherapy for ED: studied doses were about 120 mg/day (40mg three times daily as in the Stanislavov trials)
- •L-arginine combination (Stanislavov protocol): pycnogenol 40mg 3×/day + L-arginine 1.7g 3×/day — most evidence-based combination
- •L-citrulline alternative combination: this specific combination has not been trialed for ED; citrulline raises plasma arginine more sustainably than arginine itself, so some suggest it as an alternative
- •Timeline: 2–3 months for maximum benefit per trial data; some improvement possible at 4 weeks
- •Safety: well-tolerated; minimal adverse effects at studied doses; mild GI upset possible; avoid in pine allergy; antiplatelet effect — caution with anticoagulants
- •Quality: look for standardized French maritime pine bark extract (Pycnogenol brand or equivalent) — standardized to ≥65–70% procyanidins
Who Is the Best Candidate for This Combination?
The pycnogenol + L-arginine (or L-citrulline) combination is most rationally suited to men whose ED has a vascular or endothelial component — meaning circulation and blood vessel function are the limiting factor rather than nerve damage, severe structural venous leak, or hormonal deficiency. This includes men with mild cardiovascular risk factors, early diabetic vascular changes, or general age-related endothelial decline where NO bioavailability is genuinely reduced. Men whose ED stems primarily from psychological causes, nerve damage after prostatectomy, or severe organic vascular disease are less likely to see this combination alone resolve their ED, though it may still provide modest supportive benefit alongside primary treatment. As with most supplement interventions in this category, a trial period with objective tracking (IIEF score at baseline and 3 months) gives the clearest answer about whether it's working for a given individual.
Comparing Pycnogenol to Other Endothelial-Support Supplements
Within the broader category of supplements aiming to support endothelial function and NO bioavailability for ED, pycnogenol occupies a specific niche worth understanding relative to alternatives like L-citrulline alone, pomegranate extract, or other antioxidant-focused options. Where L-citrulline and L-arginine primarily address the substrate side of NO production — providing more raw material for the NOS enzyme to work with — pycnogenol's distinctive contribution is on the enzyme activity and protection side, stimulating eNOS expression itself and shielding existing NO from oxidative degradation. This is precisely why the combination approach outperforms either component alone in the available trial data: substrate without adequate enzyme activity or without protection from oxidative breakdown produces a smaller net NO increase than addressing both sides of the equation simultaneously. For a man deciding where to start within this supplement category, pairing a substrate-focused compound (L-citrulline being generally preferred over L-arginine for its superior bioavailability) with pycnogenol's complementary mechanism represents the most evidence-aligned combination currently available in this space.
ManCore lets you log every supplement you take alongside your daily symptoms, and automatically flags potential interactions between them.
⚠️ Are Your Supplements Safe Together?
Mixing high doses of Saw Palmetto, Zinc, and prescription medications can cause unexpected interactions or stress your body. Log your full stack in ManCore and run an automated interaction scan instantly.
Related Supplement Picks
Super Beta Prostate Supplement
Combines pumpkin seed oil with beta-sitosterol, selenium, and zinc in one daily formula.
Male Optimization Formula
Testosterone-support formula built around ashwagandha and other studied ingredients.
NOW Foods Pumpkin Seed Oil
Standardized cold-pressed pumpkin seed oil capsules — one of the most consistently reviewed PSO supplements.
Affiliate disclosure: ManCore earns a small commission on purchases made through these links at no extra cost to you.
Frequently Asked Questions
Does pycnogenol help erectile dysfunction?
Yes — particularly in combination with L-arginine. Stanislavov & Nikolova (2003) found the pycnogenol (40mg 3×/day) + L-arginine (1.7g 3×/day) combination produced erection normalization in 80% of men at 2 months and 92.5% at 3 months. Monotherapy pycnogenol has less direct evidence for ED but has established endothelial and NO-pathway benefits. The mechanism: pycnogenol stimulates NOS enzyme activity while L-arginine provides additional substrate — synergistic NO production.
What is the best pycnogenol dose for ED?
Based on Stanislavov trials: 40mg three times daily (120mg total) as part of the pycnogenol + L-arginine combination protocol. For the combination protocol: pycnogenol 120mg/day + L-arginine 5g/day (three divided doses). Alternative: pycnogenol with L-citrulline instead of L-arginine — citrulline provides more sustained arginine delivery, though this combination has not been tested in ED trials.
How long does pycnogenol take to work for erectile dysfunction?
Stanislavov trials showed progressive improvement: 32% at 1 month → 80% at 2 months → 92.5% at 3 months. Unlike PDE5 inhibitors, pycnogenol does not work acutely — it requires sustained endothelial adaptation, upregulation of eNOS expression, and reduction of vascular oxidative stress over weeks to months. Three months of consistent daily use is the evidence-based trial period before assessing full response.
Can pycnogenol be combined with a PDE5 inhibitor for extra benefit?
There's no known dangerous interaction, and the mechanisms are complementary rather than redundant — pycnogenol supports the underlying NO-production pathway over time, while a PDE5 inhibitor amplifies the downstream cGMP signal acutely at the time of sexual activity. Some men use both together, particularly during the initial months while waiting for pycnogenol's slower endothelial benefits to develop, though this combination hasn't been specifically studied in trials and should be discussed with a doctor given pycnogenol's mild antiplatelet effect.
Is pycnogenol safe to take alongside blood thinners or before surgery?
Caution is warranted — pycnogenol has a documented mild antiplatelet (blood-thinning) effect, which means combining it with prescription anticoagulants or antiplatelet medications could theoretically increase bleeding risk, and it's generally recommended to stop pycnogenol at least 1-2 weeks before any planned surgery for the same reason. Men on blood thinners or with upcoming procedures should discuss this specifically with their prescribing doctor before starting.
Does pycnogenol have benefits beyond erectile function?
Yes — pycnogenol has a broader research base in general cardiovascular and circulatory health, including studies on chronic venous insufficiency, blood pressure, and general antioxidant protection, given its origins as a well-studied botanical antioxidant compound predating its specific ED research. For men taking it primarily for erectile function, these broader vascular benefits are a reasonable secondary consideration supporting its use, since they work through the same underlying endothelial health mechanism.
Should pycnogenol be cycled, or is continuous daily use fine?
Continuous daily use is how it's been studied in the relevant trials and is generally considered fine long-term, without an established need for cycling on and off the way some other supplements are sometimes used. Given its role in supporting ongoing endothelial function rather than providing an acute one-time effect, consistent daily use is actually more aligned with how the supplement is thought to work.
Is pycnogenol worth trying for a man already on a PDE5 inhibitor who's satisfied with results?
There's less clear rationale in this case, since a man already getting satisfactory results from PDE5 inhibitor therapy alone has less to gain from an additional endothelial-support supplement — pycnogenol's value proposition is strongest for men seeking a non-pharmaceutical option, wanting to reduce reliance on on-demand medication, or not getting adequate response from PDE5 inhibitors alone.
How does pycnogenol's cost compare to other similar vascular-support supplements?
Pricing varies by brand and standardization quality, but standardized Pycnogenol-brand extract tends to cost more than generic pine bark extract products of unverified standardization, reflecting the additional quality control behind the trademarked ingredient used in the actual clinical trials — worth weighing against cheaper unstandardized alternatives that lack the same evidence backing.
Does pycnogenol require a prescription?
No — it's sold over the counter as a dietary supplement, though as with any supplement affecting bleeding risk, checking with a doctor first is worthwhile for men on other medications.